Cargando…
Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target
SIMPLE SUMMARY: Chemical inhibition of central DNA damage repair (DDR) proteins has become a promising approach in precision cancer therapy. In particular, BRCA1 and its DDR-associated proteins constitute important targets for developing DNA repair inhibiting drugs. This review provides relevant ins...
Autores principales: | Raimundo, Liliana, Calheiros, Juliana, Saraiva, Lucília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303227/ https://www.ncbi.nlm.nih.gov/pubmed/34298653 http://dx.doi.org/10.3390/cancers13143438 |
Ejemplares similares
-
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance
por: Loureiro, Joana B., et al.
Publicado: (2021) -
Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022) -
Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020) -
Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
por: Lai, Yongchang, et al.
Publicado: (2022) -
Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives
por: Zimmer, Kai, et al.
Publicado: (2021)